Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data

BACKGROUND: The nucleos(t)ide analogues (NAs) entecavir (ETV), tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) are preferred treatment options for patients with chronic hepatitis B infection (CHB). However, resistance to ETV has been reported, especially with prior exposure to ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Young‐Suk, Seto, Wai‐Kay, Kurosaki, Masayuki, Fung, Scott, Kao, Jia‐Horng, Hou, Jinlin, Gordon, Stuart C., Flaherty, John F., Yee, Leland J., Zhao, Yang, Agarwal, Kosh, Lampertico, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304567/
https://www.ncbi.nlm.nih.gov/pubmed/35178711
http://dx.doi.org/10.1111/apt.16788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304567/
https://www.ncbi.nlm.nih.gov/pubmed/35178711
http://dx.doi.org/10.1111/apt.16788

Ejemplares similares